SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- HIV
An SI Board Since October 2004
Posts SubjectMarks Bans
155 12 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
155FDA just approved the first modern all-in-one HIV pill that does not contain a cDewDiligence_on_SI-8/25/2014
154Scientists Have Cracked A Major Mystery Of HIV The difference between HIV infecJohn McCarthy-12/20/2013
153>>Cytolytic nanoparticles attenuate HIV-1 infectivity Jtuck-3/10/2013
152This may be a bad sign of things to come.... ROME -- About one in 10 adolescentrkrw-7/28/2011
151GILD, JNJ ink HIV collaboration for all-in-one Prezista + Truvada-like pill: siDewDiligence_on_SI-6/28/2011
150New Math in HIV Fight Statistical Method Evolves From Physics to Wall Street to tnsaf-6/23/2011
149Inhibition of Both HIV-1 Reverse Transcription and Gene Expression by a Cyclic Ptnsaf-6/7/2011
148Elvitegravir statig NI to Isentress with room to spare: siliconinvestor.comDewDiligence_on_SI-3/24/2011
147Telaprevir+SoC vs SoC in HCV/HIV Co-infection: siliconinvestor.comDewDiligence_on_SI-3/2/2011
146AIDS gel prevents infection in monkeys 5:00pm EST * Gel protected monkeys againtnsaf-1/6/2011
145Well, they'd better find that host factor. E3 ligase -- ligases in general tuck-9/3/2010
144IRCM researchers pave the way for a better understanding of HIV infection and AIrusset-9/3/2010
143Hi, Elroy. I replied to your duplicate posts on iHub in siliconinvestor.com and DewDiligence_on_SI-7/21/2010
142Regardless of Atripla holding second place sales, Sustiva with Truvada. I belieElroy Jetson-7/21/2010
141I believe the short 48 week duration of the ABT study does not capture what I beElroy Jetson-7/21/2010
140Table of World’s Top-Selling HIV Drugs: siliconinvestor.comDewDiligence_on_SI-7/19/2010
139ABT Reports Results of Phase-4 HIV <i>Nuke-Sparing</i> Study: silicDewDiligence_on_SI-7/19/2010
138wrong thread. :-) (sorry!)scaram(o)uche-4/15/2010
137<i>Sorry for the lousy formatting, but not going to spend the time to repascaram(o)uche-4/15/2010
136Indeed, a misspelling . . . haplotypes.Elroy Jetson-4/13/2010
135<b>The New Battle Lines in HIV</b> (updated for start of phase-3 ‘QDewDiligence_on_SI-4/12/2010
134<i>>…as shown by studies of different halopotype groups.<</i> DewDiligence_on_SI-4/12/2010
133CCR2/CCR5 pathways appear to exert control of the speed of early HIV disease proElroy Jetson-4/12/2010
132Only compound I've found with dual CCR5/CCR2 antagonist activity in HIV arenidos-4/11/2010
131I might have this in the wrong thread. I plunked it here because CCR2 is in an tuck-4/11/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News